nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexbrompheniramine—Doxylamine—Toremifene—breast cancer	0.138	0.14	CrCrCtD
Dexbrompheniramine—Bromodiphenhydramine—Toremifene—breast cancer	0.117	0.119	CrCrCtD
Dexbrompheniramine—Clofedanol—Toremifene—breast cancer	0.0951	0.0963	CrCrCtD
Dexbrompheniramine—Orphenadrine—Toremifene—breast cancer	0.092	0.0932	CrCrCtD
Dexbrompheniramine—Doxylamine—Tamoxifen—breast cancer	0.0869	0.0881	CrCrCtD
Dexbrompheniramine—Diphenhydramine—Toremifene—breast cancer	0.0817	0.0828	CrCrCtD
Dexbrompheniramine—Tripelennamine—Tamoxifen—breast cancer	0.0787	0.0797	CrCrCtD
Dexbrompheniramine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0735	0.0745	CrCrCtD
Dexbrompheniramine—Clofedanol—Tamoxifen—breast cancer	0.0597	0.0605	CrCrCtD
Dexbrompheniramine—Orphenadrine—Tamoxifen—breast cancer	0.0578	0.0585	CrCrCtD
Dexbrompheniramine—Promazine—Tamoxifen—breast cancer	0.0551	0.0559	CrCrCtD
Dexbrompheniramine—Diphenhydramine—Tamoxifen—breast cancer	0.0513	0.052	CrCrCtD
Dexbrompheniramine—Orphenadrine—SCN10A—breast cancer	0.000365	0.124	CrCbGaD
Dexbrompheniramine—Mepyramine—CYP2D6—breast cancer	0.000325	0.11	CrCbGaD
Dexbrompheniramine—Tripelennamine—CYP2D6—breast cancer	0.000301	0.102	CrCbGaD
Dexbrompheniramine—Tolterodine—CYP2D6—breast cancer	0.00024	0.0812	CrCbGaD
Dexbrompheniramine—Carbinoxamine—CYP2D6—breast cancer	0.000206	0.0697	CrCbGaD
Dexbrompheniramine—Tolterodine—CYP3A4—breast cancer	0.000206	0.0697	CrCbGaD
Dexbrompheniramine—Brompheniramine—CYP2D6—breast cancer	0.000178	0.0604	CrCbGaD
Dexbrompheniramine—Carbinoxamine—CYP3A4—breast cancer	0.000176	0.0598	CrCbGaD
Dexbrompheniramine—Chlorphenamine—CYP2D6—breast cancer	0.000175	0.0592	CrCbGaD
Dexbrompheniramine—Diphenhydramine—PTGS1—breast cancer	0.000174	0.0591	CrCbGaD
Dexbrompheniramine—Brompheniramine—CYP3A4—breast cancer	0.000153	0.0518	CrCbGaD
Dexbrompheniramine—Chlorphenamine—CYP3A4—breast cancer	0.00015	0.0508	CrCbGaD
Dexbrompheniramine—Diphenhydramine—CYP2D6—breast cancer	0.000119	0.0402	CrCbGaD
Dexbrompheniramine—Orphenadrine—CYP3A4—breast cancer	9.62e-05	0.0326	CrCbGaD
Dexbrompheniramine—Promazine—CYP3A4—breast cancer	8.78e-05	0.0297	CrCbGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CCL20—breast cancer	2.57e-05	0.00261	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR4—breast cancer	2.56e-05	0.0026	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GPER1—breast cancer	2.52e-05	0.00257	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—LPAR1—breast cancer	2.48e-05	0.00252	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRB—breast cancer	2.47e-05	0.00251	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—STARD8—breast cancer	2.47e-05	0.00251	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—NMBR—breast cancer	2.42e-05	0.00246	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—breast cancer	2.41e-05	0.00245	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—breast cancer	2.39e-05	0.00243	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—VEGFA—breast cancer	2.39e-05	0.00242	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—BRAF—breast cancer	2.35e-05	0.00239	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—PIK3CA—breast cancer	2.35e-05	0.00239	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—breast cancer	2.32e-05	0.00236	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GPER1—breast cancer	2.29e-05	0.00233	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CNR2—breast cancer	2.29e-05	0.00232	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PTGER1—breast cancer	2.25e-05	0.00229	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—NMBR—breast cancer	2.2e-05	0.00223	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	2.2e-05	0.00223	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	2.2e-05	0.00223	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—WNT1—breast cancer	2.15e-05	0.00218	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TNF—breast cancer	2.04e-05	0.00208	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PTGER1—breast cancer	2.04e-05	0.00208	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CCL27—breast cancer	2.01e-05	0.00204	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PDE2A—breast cancer	2.01e-05	0.00204	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CXCL3—breast cancer	2.01e-05	0.00204	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—breast cancer	1.99e-05	0.00202	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—MDM2—breast cancer	1.97e-05	0.002	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CXCL2—breast cancer	1.97e-05	0.002	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—AGTR2—breast cancer	1.97e-05	0.002	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—RAF1—breast cancer	1.97e-05	0.002	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—PTHLH—breast cancer	1.94e-05	0.00198	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—AKT1—breast cancer	1.92e-05	0.00195	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—EDNRB—breast cancer	1.88e-05	0.00191	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—WNT10B—breast cancer	1.87e-05	0.0019	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PDE2A—breast cancer	1.82e-05	0.00185	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CCL27—breast cancer	1.82e-05	0.00185	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CXCL3—breast cancer	1.82e-05	0.00185	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CALCA—breast cancer	1.71e-05	0.00174	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CXCR4—breast cancer	1.67e-05	0.0017	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CXCL12—breast cancer	1.67e-05	0.0017	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—IL6—breast cancer	1.65e-05	0.00168	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—AGTR1—breast cancer	1.51e-05	0.00154	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—RGS2—breast cancer	1.47e-05	0.00149	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CCL20—breast cancer	1.45e-05	0.00147	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—LGR6—breast cancer	1.42e-05	0.00144	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCDC88C—breast cancer	1.42e-05	0.00144	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—LPAR1—breast cancer	1.4e-05	0.00143	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GPER1—breast cancer	1.35e-05	0.00138	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SFRP1—breast cancer	1.35e-05	0.00138	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—RGS2—breast cancer	1.33e-05	0.00135	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PDE4D—breast cancer	1.33e-05	0.00135	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CCL20—breast cancer	1.32e-05	0.00134	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—breast cancer	1.31e-05	0.00133	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NMBR—breast cancer	1.3e-05	0.00132	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CNR2—breast cancer	1.29e-05	0.00131	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—LPAR1—breast cancer	1.28e-05	0.0013	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HEYL—breast cancer	1.21e-05	0.00123	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CUL5—breast cancer	1.21e-05	0.00123	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PTGER1—breast cancer	1.21e-05	0.00123	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PDE4D—breast cancer	1.2e-05	0.00122	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CNR2—breast cancer	1.17e-05	0.00119	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RSPO3—breast cancer	1.13e-05	0.00115	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AGTR2—breast cancer	1.11e-05	0.00113	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CXCL2—breast cancer	1.11e-05	0.00113	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—WWOX—breast cancer	1.1e-05	0.00112	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—WNT10B—breast cancer	1.1e-05	0.00112	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—WNT1—breast cancer	1.1e-05	0.00112	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PTHLH—breast cancer	1.1e-05	0.00112	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—HRAS—breast cancer	1.08e-05	0.0011	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CXCL3—breast cancer	1.08e-05	0.00109	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—INHBB—breast cancer	1.08e-05	0.00109	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCL27—breast cancer	1.08e-05	0.00109	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PDE2A—breast cancer	1.08e-05	0.00109	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—EDNRB—breast cancer	1.06e-05	0.00108	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DLL4—breast cancer	1.03e-05	0.00104	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—BMPR2—breast cancer	1.03e-05	0.00104	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CXCL2—breast cancer	1.01e-05	0.00103	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AGTR2—breast cancer	1.01e-05	0.00103	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PTHLH—breast cancer	9.98e-06	0.00101	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CDH5—breast cancer	9.84e-06	0.001	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CALCA—breast cancer	9.67e-06	0.000983	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—EDNRB—breast cancer	9.66e-06	0.000982	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SFRP2—breast cancer	9.65e-06	0.00098	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PRLR—breast cancer	9.47e-06	0.000962	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CXCL12—breast cancer	9.45e-06	0.00096	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CXCR4—breast cancer	9.45e-06	0.00096	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	9.44e-06	0.000959	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GLI2—breast cancer	9.15e-06	0.000929	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—VCP—breast cancer	9.15e-06	0.000929	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	9.1e-06	0.000924	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—LEPR—breast cancer	9e-06	0.000914	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	8.98e-06	0.000913	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CALCA—breast cancer	8.79e-06	0.000893	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—PIK3CA—breast cancer	8.71e-06	0.000886	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CXCR4—breast cancer	8.58e-06	0.000872	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CXCL12—breast cancer	8.58e-06	0.000872	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AGTR1—breast cancer	8.55e-06	0.000868	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	8.48e-06	0.000862	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ARHGDIA—breast cancer	8.37e-06	0.00085	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FST—breast cancer	8.15e-06	0.000828	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HEY2—breast cancer	8.05e-06	0.000818	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RPS6KB2—breast cancer	7.96e-06	0.000809	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RGS2—breast cancer	7.87e-06	0.000799	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	7.79e-06	0.000792	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCL20—breast cancer	7.78e-06	0.00079	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AGTR1—breast cancer	7.76e-06	0.000789	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ITPR1—breast cancer	7.67e-06	0.000779	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TLE3—breast cancer	7.53e-06	0.000765	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—LPAR1—breast cancer	7.53e-06	0.000765	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HEY1—breast cancer	7.46e-06	0.000758	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DLL1—breast cancer	7.31e-06	0.000743	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	7.21e-06	0.000733	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HIST1H2BK—breast cancer	7.18e-06	0.000729	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HIST1H2BC—breast cancer	7.18e-06	0.000729	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PDE4D—breast cancer	7.11e-06	0.000723	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GRB7—breast cancer	7.11e-06	0.000723	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CSF2—breast cancer	7.08e-06	0.000719	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TAB2—breast cancer	6.99e-06	0.00071	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ITPR1—breast cancer	6.96e-06	0.000708	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CNR2—breast cancer	6.93e-06	0.000704	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CXCL8—breast cancer	6.93e-06	0.000704	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—MMP3—breast cancer	6.92e-06	0.000703	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	6.9e-06	0.000701	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DKK1—breast cancer	6.77e-06	0.000688	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—VEGFC—breast cancer	6.71e-06	0.000682	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—JAG2—breast cancer	6.61e-06	0.000672	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—WNT1—breast cancer	6.52e-06	0.000662	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	6.5e-06	0.000661	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CSF2—breast cancer	6.43e-06	0.000653	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NOTCH4—breast cancer	6.18e-06	0.000628	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GZMB—breast cancer	6.14e-06	0.000624	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AGTR2—breast cancer	5.96e-06	0.000606	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CXCL2—breast cancer	5.96e-06	0.000606	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PTHLH—breast cancer	5.89e-06	0.000599	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—BMP2—breast cancer	5.89e-06	0.000599	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EDNRB—breast cancer	5.71e-06	0.00058	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PGR—breast cancer	5.65e-06	0.000574	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—THBS1—breast cancer	5.62e-06	0.000571	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FLT1—breast cancer	5.37e-06	0.000545	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGF3—breast cancer	5.34e-06	0.000543	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SQSTM1—breast cancer	5.34e-06	0.000543	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	5.32e-06	0.00054	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—JAG1—breast cancer	5.28e-06	0.000536	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PARP1—breast cancer	5.25e-06	0.000534	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NOTCH3—breast cancer	5.25e-06	0.000534	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CALCA—breast cancer	5.19e-06	0.000527	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RPS6—breast cancer	5.13e-06	0.000521	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGF4—breast cancer	5.09e-06	0.000517	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CXCL12—breast cancer	5.07e-06	0.000515	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CXCR4—breast cancer	5.07e-06	0.000515	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PAK1—breast cancer	4.98e-06	0.000506	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TCF7L2—breast cancer	4.89e-06	0.000497	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AKT2—breast cancer	4.87e-06	0.000494	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PIK3CG—breast cancer	4.83e-06	0.000491	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HSP90AA1—breast cancer	4.71e-06	0.000479	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NOTCH2—breast cancer	4.71e-06	0.000479	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	4.67e-06	0.000475	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PRL—breast cancer	4.58e-06	0.000466	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AGTR1—breast cancer	4.58e-06	0.000466	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADAM10—breast cancer	4.52e-06	0.000459	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—STK11—breast cancer	4.52e-06	0.000459	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PLG—breast cancer	4.47e-06	0.000454	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AKT2—breast cancer	4.42e-06	0.000449	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGF10—breast cancer	4.39e-06	0.000447	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PIK3CD—breast cancer	4.24e-06	0.000431	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PDGFA—breast cancer	4.24e-06	0.000431	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TGFBR2—breast cancer	4.18e-06	0.000425	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ITPR1—breast cancer	4.11e-06	0.000418	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ERBB4—breast cancer	4.09e-06	0.000415	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—STAT5A—breast cancer	4.09e-06	0.000415	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MMP3—breast cancer	4.09e-06	0.000415	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	4.07e-06	0.000414	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SMAD4—breast cancer	3.96e-06	0.000402	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IGF1R—breast cancer	3.93e-06	0.0004	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	3.92e-06	0.000398	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HES1—breast cancer	3.86e-06	0.000393	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NCOR1—breast cancer	3.84e-06	0.00039	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	3.84e-06	0.00039	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CSF2—breast cancer	3.8e-06	0.000386	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGF1—breast cancer	3.8e-06	0.000386	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—RAF1—breast cancer	3.79e-06	0.000385	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NRG1—breast cancer	3.77e-06	0.000383	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—H2AFX—breast cancer	3.74e-06	0.00038	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—IL2—breast cancer	3.74e-06	0.00038	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—E2F1—breast cancer	3.72e-06	0.000378	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	3.7e-06	0.000376	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SPP1—breast cancer	3.57e-06	0.000363	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CXCL8—breast cancer	3.56e-06	0.000361	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ERBB3—breast cancer	3.53e-06	0.000359	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGFR2—breast cancer	3.53e-06	0.000358	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—IL2—breast cancer	3.4e-06	0.000345	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TERT—breast cancer	3.39e-06	0.000344	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGFR1—breast cancer	3.29e-06	0.000334	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HIF1A—breast cancer	3.24e-06	0.000329	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—LEP—breast cancer	3.16e-06	0.000321	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CAV1—breast cancer	3.13e-06	0.000318	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—KDR—breast cancer	3.1e-06	0.000315	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ESR1—breast cancer	3.02e-06	0.000307	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FN1—breast cancer	2.98e-06	0.000303	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NFKBIA—breast cancer	2.95e-06	0.000299	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NOTCH1—breast cancer	2.92e-06	0.000296	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—APC—breast cancer	2.85e-06	0.00029	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PIK3CG—breast cancer	2.85e-06	0.00029	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—KIT—breast cancer	2.85e-06	0.00029	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EGF—breast cancer	2.82e-06	0.000287	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—MAPK3—breast cancer	2.73e-06	0.000278	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—BRAF—breast cancer	2.68e-06	0.000272	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IGF1—breast cancer	2.61e-06	0.000265	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AKT2—breast cancer	2.61e-06	0.000265	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—EGFR—breast cancer	2.6e-06	0.000264	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PIK3CD—breast cancer	2.51e-06	0.000255	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	2.48e-06	0.000252	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SERPINE1—breast cancer	2.48e-06	0.000252	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—KRAS—breast cancer	2.46e-06	0.000249	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NOS3—breast cancer	2.37e-06	0.000241	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	2.26e-06	0.000229	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MDM2—breast cancer	2.25e-06	0.000228	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RAF1—breast cancer	2.24e-06	0.000227	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RELA—breast cancer	2.23e-06	0.000226	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ERBB2—breast cancer	2.21e-06	0.000225	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MTOR—breast cancer	2.19e-06	0.000222	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PIK3CB—breast cancer	2.19e-06	0.000222	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CXCL8—breast cancer	2.1e-06	0.000213	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HRAS—breast cancer	2.09e-06	0.000212	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CDKN1B—breast cancer	2.05e-06	0.000208	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AKT1—breast cancer	2.03e-06	0.000206	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CASP3—breast cancer	2.01e-06	0.000204	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IL2—breast cancer	2.01e-06	0.000204	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—IL6—breast cancer	2e-06	0.000203	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCND1—breast cancer	1.96e-06	0.000199	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—JUN—breast cancer	1.95e-06	0.000198	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.94e-06	0.000197	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MMP9—breast cancer	1.9e-06	0.000193	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.89e-06	0.000192	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PTEN—breast cancer	1.89e-06	0.000192	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.85e-06	0.000188	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.84e-06	0.000187	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SRC—breast cancer	1.75e-06	0.000178	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.71e-06	0.000173	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—STAT3—breast cancer	1.69e-06	0.000172	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.61e-06	0.000164	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MYC—breast cancer	1.57e-06	0.000159	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.57e-06	0.000159	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EGFR—breast cancer	1.54e-06	0.000156	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—KRAS—breast cancer	1.45e-06	0.000147	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.33e-06	0.000135	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TP53—breast cancer	1.29e-06	0.000131	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HRAS—breast cancer	1.23e-06	0.000125	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IL6—breast cancer	1.18e-06	0.00012	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AKT1—breast cancer	1.09e-06	0.000111	CbGpPWpGaD
